A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Recruiting

Phase 3

DT120A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Sponsor:

Definium Therapeutics US, Inc.

Code:

NCT07592689

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

DT120

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-23. This information was provided to ClinicalTrials.gov by Definium Therapeutics US, Inc. on 2026-05-18.